Latin America NGS Market (2025-2032)
The Latin America NGS Market was valued at $273.2 million in 2024. This market is expected to reach $765.2 million by 2032, from an estimated $307.7 million in 2025, at a CAGR of 13.9% during the forecast period 2025-2032. Latin America NGS Market Size & Forecast The speed, throughput, and accuracy
- Published
- Feb 2024
- Pages
- 170
- Format
- PDF + Excel
- Report ID
- MRHC - 1041097
- Base year
- 2024
- 2024 · BASELINE
- $273.2M
- 2032
- $765.2M
- CAGR 2025–2032
- 13.9%
2024 baseline · 2025–2032 forecast at 13.9% CAGR · hover a bar for the value
Key highlights
Consumables Segment to Account for the Largest Share of the Market in 2025
Targeted Genome Sequencing Segment to Account for the Largest Share of the Market in 2025
Sequencing by Synthesis Segment to Account for the Largest Share of the Market in 2025
Research Applications Segment to Account for the Largest Share of the Market in 2025
Pharmaceutical & Biotechnology Companies Segment to Account for the Largest Share of the Latin America NGS Market in 2025
Brazil to Account for the Largest Market Share in 2025
Report summary
| Particulars | Details |
|---|---|
| Number of Pages | 170 |
| Format | |
| Forecast Period | 2025-2032 |
| Base Year | 2024 |
| CAGR | 13.9% |
| Estimated Market Size (Value) | $765.2 million by 2032 |
| Segments Covered | By Offering · Consumables · Sample Preparation Consumables · DNA Extraction and Amplification · Library Preparation & Target Enrichment · Quality Control · Other Consumables · NGS Platforms/Instruments · Software · Services · (Note: Other consumables include vials, pipettes, containers, trays, sequencing reagents, flow cells, and tubes.) · By Sequencing Type · Targeted Genome Sequencing · Whole Genome Sequencing · Whole Exome Sequencing · Other Sequencing Types · (Note: Other sequencing types include degradome sequencing, chromatin immunoprecipitation (ChIP) sequencing, and methylation sequencing.) · By Technology · Sequencing by Synthesis · Ion Semiconductor Sequencing · Single-molecule Real-time Sequencing (SMRT) · Nanopore Sequencing · DNA Nanoball Sequencing · By Application · Research Applications · Drug Discovery · Agriculture & Animal Research · Other Research Applications · Clinical Applications · Reproductive Health Diagnosis · Oncology · Infectious Diseases · Other Clinical Applications · (Note: Other research applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies, and other clinical applications include the detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and food-borne illnesses.) · By End User · Pharmaceutical & Biotechnology Companies · Hospitals and Diagnostic Laboratories · Academic Institutes & Research Centers · Other End Users · (Note: Other end users include forensic laboratories & security agencies, food & beverage companies, and agriculture companies.) |
| Countries Covered | Latin America (Brazil, Mexico, Argentina, Chile, and Rest of Latin America) |
| Key Companies | Thermo Fisher Scientific Inc. (U.S.), Illumina, Inc. (U.S.), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), and 10X Genomics, Inc. (U.S.). |
Report overview
Segments covered: offering. Regions: Latin America.
The speed, throughput, and accuracy of Next-Generation Sequencing (NGS) have revolutionized genetic analysis, enabling its use in various applications. NGS technology has found applications in genomic and clinical research, reproductive health, and environmental, agricultural, and forensic science. It has the potential to become the ultimate genotyping platform for human identification. The capabilities of NGS extend to forensic markers, including short tandem repeats (STR) and mitochondrial and Y-chromosome haplotypes. The decreasing cost of sequencing per base, along with the introduction of cost-effective benchtop laboratory sequencers, has driven the incorporation of discrete NGS data within the clinical arena for personalized medicine.
The growth of the Latin America NGS market can be attributed to various factors, including the increasing initiatives by governments and organizations for genomic sequencing projects, advancements in sequencing procedures, decreasing costs of genome sequencing, a rise in cancer prevalence, and the expanding application of NGS in cancer treatment and research. However, the high costs of NGS systems and consumables and the availability of alternative technologies restrain the market's growth.
The rising adoption of bioinformatics and genomic data management solutions, as well as collaborations and partnerships to support next-generation sequencing, are expected to create market growth opportunities. However, the lack of skilled professionals and ethical and legal issues related to NGS-based diagnosis pose a significant challenge to the market's growth.
Report infographic
Market dynamics
5 factors across 2 forcesIn March 2024,
MGI Tech Co., Ltd. (China) collaborated with Pensabio (Brazil) to assist a massive national genomic sequencing initiative using a sequencer. The objective of the project was to sequence the entire genomes of thousands of patients with hereditary cancers and rare diseases, search for genetic markers to monitor inherited diseases for early diagnosis, and stimulate technological advances and scientific development in the country by improving the growth of the Brazilian genomic industry.
In December 2022,
the oriGen project was launched to analyze the genomes of over 10,000 Mexicans. This initiative is a collaboration among several genomic leaders with the goal of improving precision and preventative healthcare in Mexico.
Table of contents
13 chapters · 95 sections · 170 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Offering | Consumables | — |
| By Sequencing Type | Targeted Genome Sequencing | — |
| By Technology | Sequencing by Synthesis | — |
| By Application | Research Applications | — |
| By End User | Pharmaceutical & Biotechnology Companies | — |
By Offering
- Consumables Segment to Account for the Largest Share of the Market in 2025
- The consumables segment is expected to account for the largest share of the Latin America NGS market.
- The recurring use of consumables, rising demand for NGS-based diagnostic tests, and increasing applications of NGS in oncology, reproductive health diagnosis, and drug discovery are increasing the demand for consumables, contributing to the large market share of this segment.
By Sequencing Type
- Targeted Genome Sequencing Segment to Account for the Largest Share of the Market in 2025
- The targeted genome sequencing segment is expected to account for the largest share of the Latin America NGS market.
- Targeted genome sequencing significantly reduces the cost per sample over whole genome shotgun sequencing by enabling sequencing of only the desired regions of a genome.
- Furthermore, the early success of targeted sequencing methods has created a rapidly growing demand for targeted sequencing in areas such as cancer, human genetic disease, and the validation of genome-wide association studies.
- These factors have increased the adoption of targeted genome sequencing, contributing to the large market share of this segment.
By Technology
- Sequencing by Synthesis Segment to Account for the Largest Share of the Market in 2025
- The sequencing by synthesis segment is expected to account for the largest share of the Latin America NGS market.
- The large share of this segment is primarily attributed to the high accuracy of this technology in DNA sequencing, its highest yield of error-free throughput, and the increasing incorporation of this technology in NGS products.
By Application
- Research Applications Segment to Account for the Largest Share of the Market in 2025
- The research applications segment is expected to account for the largest share of the Latin America NGS market.
- The large market share of this segment is attributed to the rising adoption of sequencing-based tests in laboratories, the growth in NGS-based research activities, and the increasing collaborations between market players in research programs for personalized medicine and genetic testing.
- For instance, in May 2024, BGI Genomics Co., Ltd. (China) collaborated with Universidad Mayor (Chile) to provide full NGS solutions comprising sequencing platforms and other equipment to support the university's precision oncology center.
- Similarly, BGI Genomics Co., Ltd. (China) signed an agreement with Biocódices SA (Argentina) to deliver advanced noninvasive prenatal genetic testing technologies, with the goal of reducing the cost of NIPT for Argentine consumers.
By End User
- Pharmaceutical & Biotechnology Companies Segment to Account for the Largest Share of the Latin America NGS Market in 2025
- The pharmaceutical & biotechnology companies segment is expected to account for the largest share of the Latin America NGS market.
- The large market share of this segment is attributed to factors such as the increasing adoption of advanced technologies for research purposes, increasing research for drug discovery with widening NGS applications, and the rising incidence of chronic diseases.
- For instance, according to GLOBOCAN, in 2020, 592,212 people were diagnosed with cancer in Brazil.
- This number is projected to reach 786, 686 by 2032.
- Additionally, in 2020, 195,499 people were diagnosed with cancer in Mexico.
- This number is projected to reach 254, 665 by 2032.
Geographic analysis
Latin America
Largest shareIn 2025, Brazil is expected to account for the largest share of the Latin America NGS market. growing adoption of NGS technology among healthcare professionals for the treatment of diseases, and an increasing number of sequencing projects such as the Brazilian Initiative on Precision Medicine (BIPMed), The ZiBRA project, and DNA do Brasil (DNABr). Brazil to Account for the Largest Market Share in 2025 Brazil’s significant market share can be attributed to the rising healthcare expenditure, rising cancer cases,
Competitive landscape
- Thermo Fisher Scientific Inc. (U.S.)
- Illumina, Inc. (U.S.)
- Qiagen N.V. · Netherlands
- F. Hoffmann-La Roche Ltd · Switzerland
- PerkinElmer, Inc. (U.S.)
- Agilent Technologies, Inc. (U.S.)
- Danaher Corporation (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Oxford Nanopore Technologies Plc. (U.K.)
- 10X Genomics, Inc. (U.S.)
Frequently asked questions
This study offers a detailed assessment of the Latin America NGS market, including the market sizes and forecasts for various segmentations like offering, sequencing type, technology, application, and end user. This report also involves the value analysis of various segments and sub-segments of NGS at the country level.
Cite this report
Meticulous Research. (2024). Latin America NGS Market - Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 1041097). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/latin-america-ngs-market-5780